What is a stock summary page? Click here for an overview.
Business Description
Enzon Pharmaceuticals Inc
NAICS : 325414
SIC : 2836
ISIN : US2939041081
Description
Enzon Pharmaceuticals Inc is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.06 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | -0.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -44.2 | |||||
| 3-Year EPS without NRI Growth Rate | 30.7 | |||||
| 3-Year Book Growth Rate | -14.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.49 | |||||
| 9-Day RSI | 41.1 | |||||
| 14-Day RSI | 42.06 | |||||
| 3-1 Month Momentum % | -47.39 | |||||
| 6-1 Month Momentum % | -19.89 | |||||
| 12-1 Month Momentum % | -12.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 28.1 | |||||
| Quick Ratio | 28.1 | |||||
| Cash Ratio | 27.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -5103.85 | |||||
| Net Margin % | 2992.31 | |||||
| FCF Margin % | 4312.5 | |||||
| ROE % | 24.92 | |||||
| ROA % | 1.65 | |||||
| ROIC % | -317.54 | |||||
| 3-Year ROIIC % | -4014.77 | |||||
| ROCE % | -2.87 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.14 | |||||
| Price-to-Tangible-Book | 2.33 | |||||
| Price-to-Free-Cash-Flow | 6.25 | |||||
| Price-to-Operating-Cash-Flow | 6.25 | |||||
| EV-to-EBIT | 29.68 | |||||
| EV-to-EBITDA | 29.68 | |||||
| EV-to-Revenue | -1514.77 | |||||
| EV-to-FCF | -35.15 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 2.33 | |||||
| Price-to-Net-Cash | 2.33 | |||||
| Earnings Yield (Greenblatt) % | 3.36 | |||||
| FCF Yield % | 14.51 | |||||
| Forward Rate of Return (Yacktman) % | 290.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzon Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.024 | ||
| EPS (TTM) (€) | -0.009 | ||
| Beta | 0.23 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 148.68 | ||
| 14-Day RSI | 42.06 | ||
| 14-Day ATR (€) | 0.006874 | ||
| 20-Day SMA (€) | 0.076275 | ||
| 12-1 Month Momentum % | -12.96 | ||
| 52-Week Range (€) | 0.0485 - 0.23 | ||
| Shares Outstanding (Mil) | 74.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzon Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzon Pharmaceuticals Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzon Pharmaceuticals Inc Frequently Asked Questions
What is Enzon Pharmaceuticals Inc(STU:EZ1)'s stock price today?
The current price of STU:EZ1 is €0.07. The 52 week high of STU:EZ1 is €0.23 and 52 week low is €0.05.
When is next earnings date of Enzon Pharmaceuticals Inc(STU:EZ1)?
The next earnings date of Enzon Pharmaceuticals Inc(STU:EZ1) is 2025-05-09 Est..
Does Enzon Pharmaceuticals Inc(STU:EZ1) pay dividends? If so, how much?
Enzon Pharmaceuticals Inc(STU:EZ1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers